Immune responses against severe acute respiratory syndrome coronavirus induced by virus‐like particles in mice
Open Access
- 19 October 2007
- journal article
- Published by Wiley in Immunology
- Vol. 122 (4) , 496-502
- https://doi.org/10.1111/j.1365-2567.2007.02676.x
Abstract
Virus-like particles (VLPs) represent a promising vaccine against severe acute respiratory syndrome coronavirus (SARS CoV). In this study, recombinant baculovirus vAcS and vAcME were constructed to express the S protein and the M and E proteins of SARS CoV, respectively. Electron microscope analysis demonstrated the formation of VLPs in vAcME and vAcS coinfected insect cells. Mice immunized four times with VLPs developed high antibody titres against SARS CoV. In addition, VLPs elicited cell-mediated immunity as demonstrated by enhanced interferon-γ and interleukin-4 production. VLPs also conferred protective immunity against the infection of Spike protein pseudotyped murine leukaemia virus. Our findings demonstrate that SARS CoV VLPs are immunogenic and can elicit strong SARS CoV-specific humoral and cellular immune responses in mice. This is the first study describing the immunogenicity of SARS CoV VLPs, providing valuable data for developing a protective vaccine against SARS CoV infection.Keywords
This publication has 35 references indexed in Scilit:
- Antigenic and Immunogenic Characterization of Recombinant Baculovirus-Expressed Severe Acute Respiratory Syndrome Coronavirus Spike Protein: Implication for Vaccine DesignJournal of Virology, 2006
- Virus-Like Particle (VLP) Vaccine Conferred Complete Protection against a Lethal Influenza Virus ChallengeViral Immunology, 2005
- Immunization with Hepatitis C Virus-Like Particles Induces Humoral and Cellular Immune Responses in Nonhuman PrimatesJournal of Virology, 2004
- Assembly of human severe acute respiratory syndrome coronavirus-like particlesBiochemical and Biophysical Research Communications, 2004
- Amino Acids 270 to 510 of the Severe Acute Respiratory Syndrome Coronavirus Spike Protein Are Required for Interaction with ReceptorJournal of Virology, 2004
- The nucleocapsid protein of the SARS coronavirus is capable of self-association through a C-terminal 209 amino acid interaction domainBiochemical and Biophysical Research Communications, 2004
- The Genome Sequence of the SARS-Associated CoronavirusScience, 2003
- Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory SyndromeScience, 2003
- The Small Envelope Protein E Is Not Essential for Murine Coronavirus ReplicationJournal of Virology, 2003
- Identification of a Receptor-Binding Domain of the Spike Glycoprotein of Human Coronavirus HCoV-229EJournal of Virology, 2003